Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older
May 1, 2013, 00:00
10.1016/j.jval.2013.03.884
https://www.valueinhealthjournal.com/article/S1098-3015(13)00955-8/fulltext
Title :
Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00955-8&doi=10.1016/j.jval.2013.03.884
First page :
A176
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
433